Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Ardea Biosciences, Inc. PR Newswire DALLAS, May 1, 2012 DALLAS, May 1, 2012 /PRNewswire/ -- Securities...
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Ardea Biosciences, Inc. (“Ardea” or the “Company”...
The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Ardea Biosciences, Inc. in Connection with the Sale of the Company to...
Law Office of Brodsky & Smith, LLC Announces Investigation of Ardea Biosciences, Inc. PR Newswire BALA CYNWYD, Pa., April 24, 2012 BALA CYNWYD, Pa., April 24, 2012 /PRNewswire/ -- Law office of...
Law Offices of Howard G. Smith announces that it is investigating potential claims against the Board of Directors of Ardea Biosciences, Inc. (“Ardea” or the “Company”) (NASDAQ:...
Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/rdea) is investigating potential claims against the board of directors of Ardea Biosciences, Inc. (“Ardea” or the “Company”...
Levi & Korsinsky is investigating the Board of Directors of Ardea Biosciences, Inc. (“Ardea” or the “Company”) (Nasdaq: RDEA) for possible breaches of fiduciary duty and other...
Shareholder rights firm Robbins Umeda LLP has commenced an investigation into possible breaches of fiduciary duty and other violations of the law by members of the board of...
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Ardea Biosciences, Inc. (“Ardea” or the...
Harwood Feffer LLP Announces Investigation of Ardea Biosciences, Inc. PR Newswire NEW YORK, April 23, 2012 NEW YORK, April 23, 2012 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
